EUVIMEDEUVIMED entdecken
Crossref

Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents

Kumiko Miyashita, Kimihiro Yamashita, Makoto Miyoshi, Takaaki Nishiyama, Yuki Ise, Shun Ohsaka, Kazuya Shimizu, Noriyuki Nishimura, Yuichi Hori

Anticancer Research · 2026

DOI: 10.21873/anticanres.18076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Kumiko Miyashita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan. Hauptthemen laut MEDLINE: Deoxycytidine, Carcinoma, Pancreatic Ductal, Drug Resistance, Neoplasm, Pancreatic Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeoxycytidineCarcinoma, Pancreatic DuctalDrug Resistance, NeoplasmPancreatic NeoplasmsAntimetabolites, AntineoplasticGemcitabineAnimalsHumansMiceCell Line, TumorMonoamine OxidaseCell ProliferationNeoplastic Stem CellsAC133 Antigen

Stichwörter der Autor:innen

CD133Pancreatic ductal adenocarcinomacancer stem cellgemcitabine resistancemonoamine oxidase B

Substanzen

GemcitabineDeoxycytidineMonoamine OxidaseAntimetabolites, AntineoplasticAC133 Antigen

Autor:innen und Institutionen

  • Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.
  • Department of Internal Medicine, Kobe Medical Center, Kobe, Japan.
  • Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan; horiy@people.kobe-u.ac.jp.

Zitieren

APA

Miyashita, K., Yamashita, K., Miyoshi, M., Nishiyama, T., Ise, Y., Ohsaka, S., Shimizu, K., Nishimura, N., & Hori, Y. (2026). Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents. Anticancer Research. https://doi.org/10.21873/anticanres.18076

Vancouver

Miyashita K, Yamashita K, Miyoshi M, Nishiyama T, Ise Y, Ohsaka S, et al. Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents. Anticancer Research. 2026. doi:10.21873/anticanres.18076

BibTeX
@article{Miyashita2026,
  author = {Miyashita, Kumiko and Yamashita, Kimihiro and Miyoshi, Makoto and Nishiyama, Takaaki and Ise, Yuki and Ohsaka, Shun and Shimizu, Kazuya and Nishimura, Noriyuki and Hori, Yuichi},
  title = {Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18076}
}
Kostenlos starten →